Tradestie Institutional Equity Comparison Engine

IMNM vs VTYX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VTYX Overall Edge

VTYX Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ventyx Biosciences, Inc. Common Stock (VTYX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IMNM trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus VTYX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, IMNM sits in BREAKDOWN (8th %ile IV; Dealer Gamma Walls on Pro) against VTYX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
IMNM N/M vs VTYX N/M Fwd P/E
Growth & Margin Winner VTYX
Op Margin 0.0% vs 0.0% ยท YoY -100.0% vs +0.0%
Momentum & Technical Winner VTYX
1Y +8.7% vs +786.1% ยท 52W Pos 13% vs 55%
Options & Structure Winner VTYX
BREAKDOWN (8th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
IMNM NASDAQ
Immunome, Inc.
Pharmaceutical Preparations
$17.95
-4.4% 1D
Market Cap $2.2B
1M Return +8.96%
1Y Return +8.69%
Forward P/E N/M
Unified AI Score
41.1 / 100 SELL
Tech 25.0 Fund 46.0 Flow 65.0 Mom 60.0
VTYX NASDAQ
Ventyx Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$14.00
+0.14% 1D
Market Cap $1.0B
1M Return +0.36%
1Y Return +786.08%
Forward P/E N/M
Unified AI Score
50.4 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 69.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMNM +8.69% VTYX +786.08% Spread: +16.13 pp (VTYX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IMNM TTM Op. Margin: 0.0% VTYX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMNM vs VTYX. Trailing 12-month operating profitability (IMNM 0.0% vs VTYX 0.0%) and valuation multiples (IMNM N/M vs VTYX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMNM (1) vs VTYX (5)
Institutional Metric IMNM VTYX Criterion Row Winner
Market Capitalization Scale $2.2B $1.0B Larger Scale IMNM
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% +0.0% Higher Growth VTYX
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -78.7% -45.4% Higher ROE VTYX
52-Week Range Position Momentum 13% ($16โ€“$30) 55% ($1โ€“$25) Stronger Trend VTYX
Beta / 30D Volatility Risk Regime 1.54ฮฒ ยท 62% Vol 2.07ฮฒ ยท 2% Vol Lower Realized Risk VTYX
Unified Institutional Score Composite Signal 41.1 / 100 (SELL) 50.4 / 100 (HOLD) Higher Composite VTYX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMNM vs VTYX Buy Guide
IMNM BREAKDOWN
62d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live IMNM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VTYX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live VTYX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMNM nor VTYX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.